Council for Tobacco Research
Report of the Sloan-Kettering Institute for Cancer Research [St]
Fields
- Type
- ANNUAL REPORT
- Master ID
- 10416422-6486
- Request
- 135
- Depository Date
- 28 Jun 1996
- Named Person
- Alfred, P. Sloan Foundation
- Nci
- Memorial Hospital For Cancer Allied Disease
- Nih
- Cornell Univ
- Hew
- Adams, R.
- Bale, W.F., Univ Rochester School, O.F. Medicine And Dentistry
- Bang, O.
- Bearn, A.G.
- Boyer, M.W.
- Bradley, S.E., Columbia Univ College Physicians Surgeons
- Bronk, D.W.
- Case, E.N.
- Cohen, S.S.
- Cole, W.H.
- Coombe, R.G.
- Deitrick, J.E., Cornell Univ Medical College School, O.F. Medicine
- Delafield, E.C.
- Dixon, F.J., Scripps Clinic And Research Foundation
- Donner, F.G.
- Dunphy, J.E., Univ, C.A. San Francisco Medical Center
- Eagle, H., Albert Einstein College, O.F. Medicine, N.Y.
- Ellerman, W.
- Fisher, H.W.
- Hinsey, J.C.
- Hirst, G.K., Public Health Research Inst
- Horsfall, F.L.
- Kettering, E.W.
- Lombard, R.D.
- London, I.M., Albert Einstein College, O.F. Medicine, N.Y.
- Macloed, C.M.
- Mcdermott, W., Cornell Univ Medical College School, O.F. Medicine
- Medawar, P., Natl Inst For Medical Research
- Medawar, S.P., Natl Inst For Medical Research
- Meyer, A.
- Patterson, E.C.
- Piore, E.R.
- Rockefeller, L.S.
- Rous, P., Rockefeller Univ, N.Y. Ny
- Schmidt, B.C.
- Schmitt, F.O., M.A. Inst, O.F. Technology
- Skipper, H.E., Kettering Meyer Laboratory, S. Research Inst
- Sloan, A.P.
- Smith, H.V.
- Stecher, R.M.
- Stetson, C.A., N.Y. Univ School, O.F. Medicine
- Strawbridge, R.E.
- Tamm, I., Rockefeller Univ, N.Y. Ny
- Tatum, E.L., Rockefeller Univ, N.Y. Ny
- Thomas, L., N.Y. Univ School, O.F. Medicine
- Walker, J.M.
- Author
- Sloan Kettering Inst
- Box
- 195
- UCSF Legacy ID
- bpr4aa00
Document Images
Report of the
Sloan-Kettering Institute
for Cancer Research
t
l
CONTENTS
$EPORT OF THE CHAIRMAN
OF THE BOARD OF TRUSTEES
AND THE PRESIDEXT .................. .......................... 3
t
G
l
I
C0utt: Two "bridgrs" (a rrott:s) may be sccn cs-
trrtdi»g from a cancrrua.s rrvoase cell to adjacent
siormal hamster celh~. The bridge growing from
the rig/tt 0 tlFr maasc cell C!Mflirctg with the
NltclrPts of a normal AaP)7gtfr CPll. The bridge f r<q)i
iRc left of the mousc ccll does not appear to c.r-
tr>rc1 A, porrd the cell mcmbrmtr of thc Anvrtsfrr cell
with which it bv connected. Pine, hlame>amcs
bridge,, aec»: to bc f orari>rg f rortt otlrer maftg>tattt
rrmw-r crliq r rotcr:ded, brighter cep: I attd rx7cnd
ix,o toward neighboring normal cells. rSec de-
srriptimt itt text, pages 16 and 17.) !Alag» i fieam
tintr: abnut X
IMMUNE REACTIONS .. ........... .............................. 7
DNA AND CANCER ............... ............................. .... 13
ELECTRON 1b1ICRUSCOPY . ..................................... 19
ADVAN CES IN SURGERY ............... .......................... 25
ADVANCES IN CHEMOTHERAPY ..................... 29
SOLVING THE PUZZLE ............................................ $3
OFFICERS ........................................................................ $5
BOARD OF TRUSTEES ... .. ........... ... ... ... . .............. 35
BOARD C!F SCIENTIFIC CONSULTANTS......... 36
PROFESSION AL STAFF ................... ......................... 3$
CERTIFICATE OF AUDIT AND
FINANCIAL STATEMENT .................................... 41
STAFF PC1BLICATIONS ........... .... -.......... 47

rl
y.

Thl rrprn1 i!; dircctcd to those individua)s
;1np1 orrfianir.:ltic,ns whnsc suppcut makes pos-
silde tilr actltitii:s of the Sloan-liettering in-
s1 rtutv f4,r tctncvr I.csearch. Tu illu>tratc that
pr t>~1 ts is 6cint* made rn understanding and
cnuollmg thc diseasc, sonir recent research
dh% clol,mcnt, will Lr dczcrihed, and an 1t-
Icnllt mtll lit maclc to furtliah a pcrspcctivr
in whlch 1hiv nta-i l,r ticwcii.
Th-- imtrtnto'., 2J rrst,arch dirisimns. maclt-
ul, (d almort lM' rat:udhsrcllal~sl are wurkI )nII Iq. achivcv:ul umhrctandinK of th
torit:irt
nf thv c:lm uru: statv. and to improve mcth-
od, 14 trcating c.istlnl; tiiscnsc. The number
urrd Narict% 1.1' intcMlFatlce ap)tt'oaclteg cng-
gist thr comploxit.% of tht prohkmts facing
Thrut:h th, cra~~.tlr~rihhnar~
cfTorrt, tlult'hwd h. m:rnv divcmr stuclics. sci-
tnti>i, hoql cNcntu:rll~ 1o unr'avcI 1hr m.%,.
tt-riv 1d ranc~r.
llnrllig 19Gr )uny;l'anl, in hasii'. nhl1fiucl.
vtd cluuc-;rI r4:<c;u'ch mrr, d1N'tlapcd and
ehul }t,i t tah, :ultantapu t,f rtlcr;ult ad
v;uu,. tn thw IthYslc;ll. m;ithtmatical. and
lnf,logltal .rlcncc. f'criaun resc:u:h nctitititr
woYr :1ddvd, (W t11mcWltlllnt'd. fOl11'
17P%% d1\I,Inll. 0vl1 liwahcmi.stry. K;I/llothcl-
;1pi l:c,c:n'c Il. Alqdlul Thrl;rl+y alld 1'ItYCitil)

Biology. were added during 1968. and two
divisions, Experi;nenial Patholog and.liicro-
biolop'y, +tete discontinued. The Divisions of
Biomathematics. Biochemistry. Endocrinol-
ogr, Rinpl.csics. .llctiical Research. Biological
Cnemistry. Surgicul Research, Environmen-
tal ('anccrigenesis. Chemotherapy Research,
Cytology. (:cnctics. \'iroloF}', Cell Biology.
and Pharmacology were enlarged through
additions to staff.
0114, of tht' ,re;ur's most signifi' ant events
was the improvement in research facilities
accomplished throuQh the reopening of thc
Howard Lahttrattu:y, the original research fa-
cility of the institutr. Extensive recnnMruc-
tion and renovation of the 14-story building
was ~tarttd in Fcht'uary. 1467. A S1.a39.00t1
grant from tht National lnstitules of health
and n $3 million t*r;)nt from the rllfietl P.
Sloan Founcl:ltlun lnn+itletl the iatfiesl por-
tirnl of funtl-A fortht. mndrt'nization of all laho
1'ato)'tes a11d tltr l,t.rchacc atld in-Mnlla'inn of
sut/!--tanli;el nt'n lahnrat-',r,r equipment.
The new llttn:utl l.nlttuatuty, which has
direct nccos, t., 1ht ,tth;utnt Urmr+rial llos-
pital for ('t ncer and ,>,lliod 11isr:tse's. hou!~es
tllt' 111~111U1~' c f'11nit;lll-v ol'it',lltyl 1't:at`al't'h
groups. i:xecuti+e otlicc, of the institulc' are
alsn lt,c;ttt'd in 1he llo++tutl l.uluuntut;c.
Control antl mnnnwement of Slaan-l:etter-
ing lnSt1tutt. ftttnlded in Itll:,. is in thehand>
of the Iit,vvl of Trustees, elected annuall>.
Changes in Nutrd mt'm1ic1'shil, durinF 19GS
inclwled 1he resiFn;ttitm tif I tt. Rn~t'r ,ltlants.
after 1:}e;u'~ uf set'+tct a a Trurtct' of tht'
instittltc. and the resignatinn of Evcrelt
\ Case. a mt'mlwr for t++o ycats. Tltril ntanr
cnntrihutinns tr the instttnle aue 1,*rattfn11Y
;erkno++lct)t:e'd. A netx tntml,t'r, llr. 11c l,rit
t;. honncr. wus rlrrtoi a Truste't. during 1!tf ti.
Thr ('mmmlttce on Scirntttit PrlitN of the'
Itill'tn1 t4g;ltlri;t11n11. Z)tIlln1'1711 tltKltlh0tt1'
mfi Ccntrl. dcsiFnnttd nnnuall' %. fnom
:,,,'n,lw,. of tl,t l:o1,11 f Tln,14,'s
of ti;t' nlaiUltr and the Ittrtr1l of .ll:utaFt'rs of
the Memorial Hospital, reviews and evaluates
the research programs of the various divi-
sions of the institute. The committee repol'ts
to the Board of Trustees on any aspects of
these programs that require attention of the
board. Dr. J. Englebert Dunphy. Professor
and Chairman of the Department of Surgery.
University of Califot'nia, San Francisco Diedi-
csl Center, was elected to the Committee on
Scientific Policy during 1968.
An important source of guidance to the
President and Director of the institute contin-
ues to be the Board of Scientific Consultants.
appointed by the Board of Trustees. Board
membcl s, selected from among the +rorld's
leading scientists, meet quarterly to evaluate
particular research proiect_s chosen for pres-
entatio,l. Dr. Warren H. Cole became Chair-
man of the Board of Scientific Consultants for
the term July 1, 196R-July 1, 1969, and Dr.
Alexander G. Bearn assumed the l'ice Chait'-
man:hip for the same p+riod. Three new ap-
pointments ta the board were made during
the year: Sir Peter Medawar, F.R.S., Direc-
tor of the National Institute for Medical Rt-
search, London: Dr. George 1:. Hirst, Presi-
dent and Director of the Public Health
Re.,earch Institute of the City of New York.
hlc.; and Dr. Frank J. Dixon. Chairman. Pc
partment of Exnerimental ?athology. Scripps
Clinic and Rescarch Foundation. Each uar
appointed for a three-year term. Dr. Seymour
S. Cohen submitted his resignation after
eight and one-hali years as a member.
The cloan-l:ettcring Institute for Cancer
Research functions as a teachinF ins:itutmn
at hnch prednctolal and postdoctoral le%els.
The Slonn-liettering Division. Graduate
Schttol of Metltcal Sciences, Cornell 1'ntxel
sit y t,fTers a predoctoral program to train and
tIt'yt'Inlt rcientists for original in>.'estittativc
++orl, in bittchcmistr,r, biology, biomathe
nt;ttic.s or hit+l,h.ics. Students may obtnin
tht' I'h.Tt. or .11..S. degree through this pro-
I;ratnl. Tlurt~'tt+o ctudents. n1 canelidaleF

for the Ph.D. degree, and one candidate for
the 11.S. degree, were matric+.+lated in the
Sloan-Kettering Division during 1968. Three
students were awarded the Ph.D. degree
du:ing 1968 and three others completed their
theses and will be awardea ;hP Ph.D. degree
in 1969. All of these students were supported
by the institute.
The postdoctnral program conducted by the
institute lirovides to young investigators op-
portunities to improve their competence and
to enlarge their experience in laboratory and
clinical research in cancer. During 1968, 92
postdoctoral Fellows received research train-
ing at the institute, with an average of 57
present at anY given time. Among these 92
Fello»s. the institute provided in full, the sti-
pends of 64, and in part, the stipends of th+ee.
Of those present at the end of the year. ?4
Fellm.s irere from the United States and 41
were from 16 other countries.
The total expenditures for the institute in
1968 were $10.024.497 of which government
agencies provided Rc..Op9,°i-f. The major part
of the latter sum )vas provided by a single
inshiunettt grant from the National Cancer
Institute of the United States I-lepartment of
Health. Education and Welfare. The unre-
srricted prant. representing approximately
a1.81, of the total annual operating expense
of the institute, is contingent upon the re-
ceipt from other sources of support equal to
the remaining b3.:"( of the ,rear's budget.
The remaining funds essential for support
came from more than 10,000 individual and
corhonrtc gifts, nraii. prc>senterl in memor* v of
friends and loved ones uith the hope that
others will lie spared through the fruits of
eemtinuing research. Among tihe agencies pro-
vidink such suhpott for 1r.t68 Nrere the l'.S.
Atomic Energy Cbmmission, the American
Cancer fiuciety, The Damon Runyon Fund for
Cancer Research. the New York Cancer Re-
searrh Institute. and The Health Research
t'ouncil of New York City. Maim founr:atiron
grants which suppert institute research in-
clude those from the Alfred P. Sloan Founda-
tion, the John A. 13artfoird Foundation, the
Charles F. Kettering Foundation, the Chris-
tine Sonntng Fovndation, the Elsa U. Pardee
Foundation, and the T4ax C. Fleischmann
Foundatioii of Nevada.
D1AR1oN W. BOYER
Chairm.an of the Board
FRANK L. HORFFALL, JR., bi.D.
Presidcnt and Director
6

IMMUNE
REACTIONS
.framing the questions .
One Sloan-1{ettering researcher describes
clinical cancer as the last stage of a process
whose early phases are as yet unrecognized.
Since cancer is a cellular disease, several re-
search groups at the institute are attempting
to understand its early phases through study
of cells and Eubcellular particles. Very broad-
h, cancer research at this level is directed
toward answering three general questions.
(l) No%% do cancer cells differ from normal
cells? (2) Is this difference pertinent to the
genesis of the disease? (S) Can this differ-
ence be exploited in the treatment or preven-
tion of the disease?
Immunologists at the institute have been
prominent in the elucidation of two basic dif-
ferences between normal and cancer cells.
These are the only two qualitative differences
that have been recognized to date.
The first, now widely documented, discov-
ery is the inability of certain cancer cells to
make a known amino acid, asparagirie. Nor-
mal cells can synthesize t.hissubstance in suffi-
cient quantity for their needs, utilizing en-
dogenous chemicals. Some cancer cells lack
this ability and must obtain asparagilne from
an external source, such as the bloodstream.
An enzyme, asparaginase, destroys aspara-
gine in the bloodstream, thus denving the can-
cer cells their source ot the amino acid. As it
cannot enter cells, a.cparaginase does not in-
terfere with the production of asparagine in
normal cells. By administering asparaginase
it is possille to kill asparagine-dependenl
cancer cells, leaving normal cells unaffected.
This basic difference between normal and
cancer cells qs being exploited clinically in the
treatmem of specific types of leukemia. Suc-
cess with asparaginase has led to an intensi-
fird search for other enzymes with such selec-
tivp potentidl.
A second qualitative difference between
normal and cancer cells has been ascer-
tained through immunological means. Animal
sludies have clearh demonstrated that tumor
I

Y,
cells possess antigens not shared by normal
cells.' Two categories of tumor antigens have
been defir.ed in animal cancers: (1) those that
form part of the cell surface, called "trans-
plantation antigens," because they invoke re-
jection phenomena when tumor cells are
transplanted from one animal to another:
and (2) antigens that do not form part of the
cell surface and play no part in transplant
re,iect ion.
Transplantation antigens have been found
in tumors induced by oncogenic (i.e., cancer
inducing) chemicals. It appears that each such
tumor elicits an immune response peculiar to
itself. Two tumors induced in the same arrmal
by the same chemical will generally possess
diflerent antigens. Transplantatyon antigens
are a!so found in animal leukemias and sonie
tumors induced by viruses. Such antigens
appear to be specific for a particular virus:
that is, cr.c virus will always induce the same
tn an ,plantation antigen.
Antigens that do not occur on :he cell sur-
face, or play a part in transplant re,iection,
are exemplified by the "T antigeilis" of DNA
viruses.' These antigens ve products of viral
genes. but ere not incorporated into the virus
particles. Sonte oncogenic RNA viruses also
povsess il.trarellular antigens not involved in
transplant rejection.
The de.tection of tumor antigens is impor-
tmlt in that it provides ttew approachws to
determining the cause of various cancers
le.g., presence of an antigen specific for an
oncoFenie virus %rould sugFest tlie causativc
roke of that virtl:). Of mrne immediate inr
portancl tti, thosl. ctricken with 1he clisease,
knMelvdt;, of 1umt,r antifiens providcs thc
first ra;irnlal leads to cancer immimotherapy.
This is perhah.s the most encouraging indira-
'Ar :,n.:4, r t, t l.l 1., .1, /Int ,! :u n n,.i,inf,, lmus ,,,
tnfr, l:.u !orrtgt: ,al whs, rh:nitr,:l strurhtt,
dtRor+ Qunirnrntly fr,.m t6,
1 r:gt;, r:m nnni.uu t.. t,..m.
.
tion to date that one day it may be possible
to harness the body's immujle responses for
the treatment, and ultimate prevention, of
certain forms of cancer.
A particularly exciting area of immunology
in which Sloan-Kettering investigators are
deeply interested inv'olves the search for anti-
gellic similarities among tumors occurring in
different animal species. The discovery of
such similarities may provide a key to the eti-
ology of whole groups of cancers, a sort of
"comparative oncogenesis." Techniques of
virology and immunology are incorporated in
these studies.
Since the turn of the century scientists have
speculated that one or more viruses might be
responsible for causing some cancers. In 1908
Olaf Rang and Wilhelm Ellerman demon-
strated that a cell-free filtrate (presumably
containing a virus) could produce a leukemia-
like disease in chickens. and in 1911 Peyton
Rous proved a virus could induce solid tumors
in such animals. It was 20-odd years before
any further relationships between viruses
and tumors were discovered. By now, man~
viruses have proved capable of inducing tu-
mors. in laborator,v animals.
Two very intriguir,g observations made at
the institute recently relate to viruses asso-
ciated with specific types of cancer in widely
disnalate animal species. Indications are that
researchers may be on the track of two viruses
likely to be implicated in human cancer.-,.
Dlurine lettkemia virus ("A1uLV"), an
R\ avirus, has been recognized as a causa-
tive agent in spontaneous leukemias in mice.
A similar R\ A virus, avian leukemia virus or
"ALA'," is responsible for leukemia in chick
ens. During the past few years investigators
have discovered a morphologically similar
ln uru~ ciassifirattnn, thr initial diatinctioe is madv
br1Ntefl h\A vtrus>s. whnse genetic mtiterml is dr
e\yrilinnUrlCif arl(l, and R1A virusrs, uhose genrtn
m:drt.al tt rtLnrnulrir nctd.
F

virus in cats with naturally occurring lym
phosarcomas, the most common type of can-
cer in cats. This riius has been designated
feline leukemia virus, or "FeLI'." Initially
FeLN' was detected by electron microscopy.
Under the electron microscope FeLV appears
indistinguishable from A1uLY and A)N. Its
presenc~ can also ))e determined through tests
of infectivity in living animals.
Very recently a group of scientists at Sloan-
l:ettcring conducted a series of immunologi-
cal tests ml feline leukemia virus. and the re-
lationship it bears to the murine and avian
leukemia viruses. These researchers employed
a reliahlr, and incidentalll very dramatic,
technidue in their .cork. This immunoprecipi-
tation tcc)uiiqur, called "double diffusion" or
"the Ouchterlony inethod," is illustrated pho-
trtgt:tphica)ly in Fig. 1.
The test is designed to detect precipitation
tunctions between solultle aniigens and their
antihodies. A shallow agar gel is permitted to
solidifit in aspecialh designed dish in t+1hich
a metal matrix stands. As the agar scjlidifies
and thr matrix is removed. "~~ells" are left in
thv gel. An antibiic or antigen solution is
hourrd intio cach wcll. These liquids diffuse
tlumtgh 1he gcl and meet one another. If the
antibod> and its related antigen react with
each other, laccipitation %Vill occur and ,1
light-colorrr) haml Nvill appear between the
tl+(o we)l< imoket) in ti.e reaction.
It(,)lendin upon the number and arrange.
ment (if the aclls. a single reaction may be
tested or several may be tested simultr.nr
ouSlY. t)nr u.'cful confilan;otiun i> :r centtal
wrll. Nvith n ring of wclls surrounding it. If
:~itthn,)r specific for tttt antigen of mouse leu-
krmia virus (Mul.\' ) is placed in thc central
\\rll, and extrat ts of varions RNA .irutes, in
cludinF .llul.l' extract. arc poured into the
hrralhera) «-c)6, it is )w',~Siblc to compare the
nntillod' y-antiFen rr.rctirn occurring hctwer»
the anttiUndr a+td the mouse viral antigen witL
thw.t. ricrtnring ltetmrtm thr antihodly and
rICUat 1. The OrtrGterlonv method is eraed krrc to
drmmtshntr the vridraprrad orcrrrrertcr of anti-
body to Btirkftt's lpmpb0»m ontigen. Thr renter
Uril confains $r+rki't'c llpnp4omn enfigrn. Rear-
tio»s arr fnr,nd trith blood Jronr patirnts with
BxrAitf', lyntplirnno d'tcrll D, carcinontn oJ the
pnstnasal spnri~ (nrll 2), and ltfrnphosarrmnn
( urlt ;1. /1t rw» t) n,.t, a» tibodlr is rarely drfrrfrd
in tbc bluod of rurrmnl indiEidaals or in thi blorad
f.f pntifnfs u'ifh breast canr,r (urll 5 1 or mrln-
ttiamt r w4 115 J,
antigens pns ses.sed by the other viral extracts.
1t'here idrntieal reactions occur, precipitation
bands ioiii, showing that the viruses repre-
sented share an antigen. More than one preci-
pit:dion band may form between the central
well and am other well, indicating that the
antibodY is a"mixture" and that more than
one nntibrtrdy-antigen reaction is occurring.
By placing the gel on light-sensitive paper.
and lighting from above, it is possible to Ob-
tain a photoFraphic record of the reaetion.,.
Double diffusion tests conducted with )eu-
krnti:a viruses from mice (MuLV) and cats
(Fr1.1') indicate quite conclusively that the
cat and mbusr ieukemia viruses share an anti-
grn, meaning in effect that the coats of the
.9

B
viruses are structurally related. This antigen
is not shared by the avian leukemia virus. Ex-
cited at finding this apparent immunological
relationship between diseases in animals of
widely different species, Sloan-Kettering sci-
entists are conducting similar tests to dis-
cover whether tissues and milk of hamsters
and rats, in which a similar RNA virus
occurs, have an antigen in common with cats
and mice, with chickens, or with each other.
At least one researcher in the group conjec-
tures that as viruses of this type are studied
in greater detail a related virus may be :m-
plicated in acute leukemia of children.
A second recent invnunological discovery is
perhaps even more pertinent than the cat-
mouse relationship. In this case man is in-
rolved directly, rather than by implication.
For the past decaele intense study has yielded
a series of curious fact.c concerning a type of
cancer which occurs most frequently among
children in certain parts of Africa. Called
"Burkitt's l.mphoma," this disease has sev-
eral characteristics of interest to investi-
gators. Some African Burkitt's tumor cells
grown in the laboratory are rich in herpes
type virus particles ("HTX*"). presumabh a
DNA virus of previously unknown type.
Further, antibori,v to Burkitt's }1T\' is found
in the blood of pat ients sufierinR from several
other malignant diseases, including carcinom"
of the postnasal space, l,rmphosarcoma, and
chronic lymphatic leukemia. and the nonma-
lignant disease'. infectious mononucleosis.
Prompted by the apparenth widespread uc
ctrrence of antibodies to Burkitt's HTV,
Sloan-1:ettering researchers undertook to ex-
aminc the antiFenic properties of HT\' a«o-
crnted with a naturally occurring malignanc.
in frogs, Lucke renat adenocarcinoma. Anal.--
sis of the frog viral antigens indicated that
natural antibodies against them occur widely
'Serum frrnn an amum:d .V'rnch ha* W~rn cxpnfrl to thr
~iru.. and hu~ reaNcd intntufinln~~calh' aFtuust it.
among arnphibia. Aiore surprising, the anti-
serum' to Lucke HTV prodaces strong posi-
tive reactionswhien it is tested with Burkitt's
HTV. These tests have been repeated success-
fully, and demonstrate, positively that the
human agent and the frog virus possess a
common antigen. Similar tests are now being
conducted to Zetermine whether a relation-
ship exists between either of thcse herpes-
type viruses and the NTV associated with
rAeurolynnphomatosis (lttarelk's disease) of
chickens.
The shared antigen associated with malig-
nant diseases of human beings and frogs may
i6rdicate that the herpes-type virus family
possesEes a common group antigen which cuts
across the animal kingdom. Alternatively, it
may mean that those hei pes-type viruses as-
sbciated 'with malignant diseases carry a com-
mon antigen. In either event the implications
of the discovery are of greatt interest to sci-
eintists involved in cancer research.
10

IQ
DNA
AND
CANCER
mec)tavism,o, of change
As evidence is accu=u?ated thst. a causal ie-
laXionship exists between viruses and some
forms of cancer in animals, some investi-
gators seek to integrate viral causation into
a larger concept of the nature of the disease.
One such coacFpt is that cancer, whatever the
immediate triggering factor may lie, is ulti-
mately a cell genekic disease.ll'hether a virus,
irradiation, or an oncogenic chemical initiates
the change, the cancerous cell reproduces it-
self, trat.smitting its malignant characteris-
tics to its cell progeny. It is therefore postu-
lated that cancer is a disease of DA'A, If this
interpretation is valid, then genetic material
isolated from cancer cells might differ in some
regard from that of normal cells. Evidence
for this conter:tion would be obtained if such
I)\A were capable of inducing malignant
transformation ot normal cells.
To understand the relationship between
DNA and cancer, a group of cell biochemists
at the institute has been engaged for some
years in a series of exacting, and often frus
trating. experpme~nts. One approach involves
ati attempt to define chemical differences be-
tween the gettctic deter.ninants of normal and
malignant cells. Comparisons have been made
Uetween the DNA of pormal Chinese hamster
cells and Chinese hamstt>r cells transformed
to the cnncerou.~ state through exposure to
oncogenic chemicats such as benzp,rrene (BP)
and oncofienic viruses. To date, no significant
chemical differences have been found.
hnvestieatnrs have looked for differences
between normal and fiP-transformed ce11s in
terms of their patterns of ribonucleic acid
11RNA) biosynthesis. Of the millions of gen-
etic messapes thought to be encoded in the
D`:A contained in the nucleus of a single
mammalian cell, onh a small fraction is ever
expres,-ed. The genetic messages are trsn-
sc~ribvd into a series of ribonucleic acids and
the information contained therein is trans
lated into chemical activity in the cell's cytrn
plasm. Investigators have sought some dis-
